The Kennedy Network Conference 2026 brought together students, professors, leading researchers, and distinguished keynote speakers for a vibrant and wide‑ranging exploration of advances in rheumatology and immunology. Attendees enjoyed an exciting mix of student flash talks, rich poster sessions, hands‑on...

The Kennedy Trust is delighted to welcome four new Trustees to our Board: Professor Paul Peter Tak, Dr Edith Hessel, Professor Paul Emery and Dr Tony Wood. These recognised leaders in biomedical research and commercialisation bring a breadth of experience...

The Kennedy Trust’s funding for the Arthritis Therapy Acceleration Programme (A-TAP) has contributed to new developments in the understanding of treatment for inflammatory bowel disease (IBD). In a world first, researchers at the Kennedy Institute, Oxford have mapped the cellular...

The Kennedy Trust is excited to announce a new schedule of funding calls: . . Transition Fellowship (£500k): opening October 2024 Research Ignition Awards (£100k): opening March 2025 Senior Research Fellowship (£1.5m): opening October 2025 . . Further details of...

A perspectives piece published in the Proceedings of the National Academy of Sciences (PNAS) sheds light on the importance of mechanical forces in the early activation of T cells, a critical part of the immune response. Professor Marco Fritzsche, a...

Professor Sir Ravinder Maini and Professor Sir Marc Feldmann have jointly received The Royal Society’s Royal Medal (Applied) for inventing anti-TNF therapy to treat rheumatoid arthritis (RA), bringing it from bench to bedside in one of the biggest success stories...

The Kennedy Trust’s support for the Oxford-ZEISS Centre of Excellence has contributed to the development of a new microscopy technique. The new technique, developed by researchers at the Kennedy Institute, enables detailed analysis of molecular interactions in live cell membranes,...

Over 30 years ago, the Kennedy Trust supported the early research and clinical trials that led to the discovery of anti-TNF therapy, a groundbreaking treatment that has improved the lives of millions of patients with musculoskeletal and inflammatory diseases across...

Trustees and staff at the Kennedy Trust attended a dinner hosted by the Kennedy Institute of Rheumatology in celebration of a recent donation made by the Trust to enable the endowment of two new professorships in translational medicine at the...

Following a highly competitive call, we are delighted to announce that Dr Tetsuo Hasegawa at the University of Cambridge has been awarded a prestigious Kennedy Trust Senior Research Fellowship of £1.9m over five years. The Senior Research Fellowship scheme was...